Evidence map›Paper›PMID 37786455›Full record

ArticleClinical case reports2023

Angioinvasive

Michael J Davis, Katelyn J Rypka, Alexandra K Perron, John Keilty, Benjamin Wils, Joshua Levine, Anthony T Rezcallah, Robin Solomon, Noah Goldfarb, Anjum Kaka

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. AngioinvasiveClinical case reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Michael J DavisMinneapolis VA Health Care System - Department of Infectious Diseases and University of Minnesota - Department of Infectious Diseases Minneapolis Minnesota USA.ORCID https://orcid.org/0000-0002-0724-2665
Katelyn J RypkaMinneapolis VA Health Care System - Department of Dermatology and University of Minnesota - Department of Dermatology Minneapolis Minnesota USA.
Alexandra K PerronUniversity of Minnesota Medical School Minneapolis Minnesota USA.
John KeiltyUniversity of Minnesota Medical School Minneapolis Minnesota USA.
Benjamin WilsUniversity of Minnesota Medical School Minneapolis Minnesota USA.
Joshua LevineUniversity of Minnesota Medical School Minneapolis Minnesota USA.ORCID https://orcid.org/0009-0004-0224-8824
Anthony T RezcallahMinneapolis VA Health Care System - Department of Surgery and University of Minnesota - Department of Surgery Minneapolis Minnesota USA.
Robin SolomonDepartment of Pathology Minneapolis VA Health Care System Minneapolis Minnesota USA.
Noah GoldfarbMinneapolis VA Health Care System - Department of Dermatology and University of Minnesota - Department of Dermatology Minneapolis Minnesota USA.
Anjum KakaDepartment of Infectious Diseases Minneapolis VA Health Care System Minneapolis Minnesota USA.
University of Minnesota · USUniversity of Minnesota Medical Center · USMinneapolis VA Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioinvasive dermatophytosis with necrotizing fasciitis can be a rare complication in immunocompromised patients with early surgical debridement, 12 weeks of oral terbinafine, and reduction in immunosuppression being a viable management strategy.

Indexed as

angioinvasive dermatophytosishematologic malignancyimmunosuppressionnecrotizing fasciitisterbinafineTrichophyton rubrum

Identifiers

PMID37786455
PMCPMC10541569
OpenAlexW4387219447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.